RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development HIPO Q1 2026 Earnings EPS Surges Past Estimates with 49 Beat Envela Corporation ELA Q1 2026 Earnings Massive EPS Surprise of 2285 Drives Investor Interest INLX Q1 2026 Earnings Significant EPS Miss Amidst Challenging Quarter EFX Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher EFSCP Q1 2026 Earnings Preferred Stock Steady as Common EPS Misses Estimates